Reassessment of the murine c-fms proto-oncogene sequence.
نویسندگان
چکیده
The c-fms gene encodes the receptor for the macrophage-colony stimulating factor (M-CSF) which promotes the proliferation and survival of cells of the monocytic lineage (1). A cDNA library was constructed from a murine myeloblastic leukemic cell line, BMC-4, in which the c-fms gene was overexpressed (2). Eleven independent full-length cDNAs were isolated after screening with a probe encompassing the c-fms first coding exon. The coding region of two arbitrary chosen clones was sequenced on both strands by the Sanger method. The sequence of the two clones was identical but different from the available murine c-fms sequence (3), by 24 differences at the nucleotide level which led to 12 amino acid changes. Comparison with the rat, feline and human sequences (4, 5, 6) showed that 11 of these 12 changed amino acids were present in the rat or/and in the cat and human sequences. Changes are listed in Table 1. The M-CSF receptor is a transmembrane protein with intrinsic tyrosine kinase activity, shared by two catalytic domains (TK1 and TK2) separated by a kinase insert. The tyrosine residues in the intracellular domain are the target of phosphorylation either by the receptor itself or by other cellular kinases. Moreover, tyrosine phosphorylation modulates the binding of SH2 domain-containing proteins which regulate the signalling pathway (7). It was therefore noticeable that instead of a tyrosine residue at codon 660 within the TK1 domain we found an isoleucine residue, and conversely, instead of an isoleucine at codon 829 in TK2 a tyrosine residue. These differences were not due to a polymorphism between BALB/c mouse (3) and (C57Bl/6xBALB/c)Fl mouse (our sequence), as confirmed by RT-PCR done with synthetic primers encompassing codons 660 and 829.
منابع مشابه
Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA.
By transfecting high molecular weight DNA from a Kaposi sarcoma lesion into murine NIH 3T3 cells, we have identified and molecularly cloned a set of human DNA sequences capable of inducing focus formation, growth in agar, and tumorigenicity in these cells. The human DNA sequences present in primary, secondary, and tertiary NIH 3T3 transformants encompass about 32 kilobases (kb) and contain four...
متن کاملReassessment of the v-fms sequence: threonine phosphorylation of the COOH-terminal domain.
The v-fms oncogene product of the McDonough strain of feline sarcoma virus is a member of the receptor tyrosine kinase family. Its cellular counterpart, the c-fms product, is the receptor for colony-stimulating factor 1 (CSF-1) of macrophages. We have reanalyzed the v-fms gene by direct sequencing of a biologically active clone. An additional A nucleotide was detected in position 2810 of the pu...
متن کاملPost-Transcriptional Regulation of Proto-Oncogene c-fms in Breast Cancer
In the development and progression of breast cancers, both the c-fms proto-oncogene (which encodes the tyrosine kinase receptor for CSF-1) as well as CSF-1 (colony stimulating factor1), play an important role. Evidence from transgenic models suggests that c-fms encodes for the sole receptor for CSF-1 (Dai et al, 2002). We and others have found that c-fms and/or CSF1 are expressed by the tumor e...
متن کاملRET proto-oncogene mutations in the diagnosis of medullary thyroid cancer: a review article
Medullary thyroid cancer accounts for 5-10% of thyroid carcinomas. RET proto-oncogene mutations occur in all of the hereditary MTCs and about 66% of the sporadic MTCs. So, the detection of the RET mutations is necessary for rapid and proper diagnosis and treatment. This systematic review seeks to find a comprehensive list of RET gene mutations in the diagnosis of medullary thyroid cancer. The ...
متن کاملTHE MUTATIONS OF RET PROTO-ONCOGENE IN MEDULLARY THYROID CARCINOMAS IN IRAN
MeduIIary thyroid carcinoma (MTC) occurs both sporadically and in the autosomal dominantly inherited multiple endocrine neoplasia (MEN) type 2 syndromes. The distinction between true sporadic MTC and a new mutation familial case is important for future clinical management of both the patient and family. The susceptibility gene for hereditary MTC is the RET proto-oncogene. DNA analysis for g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Nucleic acids research
دوره 21 3 شماره
صفحات -
تاریخ انتشار 1993